Dr. Enos Moyo and his colleagues address this critical question in their insightful paper, The Budget Impact of Adopting Oral Pre-Exposure Prophylaxis for HIV Prevention: A Rapid Review, Conducted at the University of KwaZulu-Natal’s School of Public Health Medicine, this research offers an in-depth analysis of the financial implications of oral PrEP adoption across various countries.
While the effectiveness of oral PrEP in reducing HIV transmission is undeniable, Dr. Moyo highlights how financial constraints remain a significant barrier to its integration into national guidelines.
The study provides key findings, including the potential for cost savings when targeting high-risk populations and reducing PrEP pricing. These insights pave the way for policymakers to develop sustainable strategies.
For more on this critical research and to hear directly from Dr. Moyo, explore our exclusive interview in Issue 6 of From the Horses’ Mouth, where he shares his vision, challenges, and next steps.
